Inventor · disambiguated record
Xiaohong Cai
Also filed as: CAI XIAOHONG
8 granted patents·11 pending applications·15 citations·filing 2005–2023
79Inventor score
Files withASCENTAWITS PHARMACEUTICALS LTD7OBI PHARMA INC5THRESHOLD PHARMACEUTICALS INC3CAI XIAOHONG2MOLECULAR TEMPLATES INC1
Top patents by PatentIndex Score
19 records- 0188US8575188B2Camptothecin derivativesCAI XIAOHONG·Filed 2010·Granted Nov 5, 2013·11 cites·17 claims
- 0279US10766914B2DNA alkylating agentsOBI PHARMA INC·Filed 2019·Granted Sep 8, 2020·1 cites·14 claims
- 0376US10364261B2DNA alkylating agentsOBI PHARMA INC·Filed 2016·Granted Jul 30, 2019·2 cites·11 claims
- 0472US10409869B2(R)- and (S)-1-(3-(3-N,N-dimethylaminocarbonyl)phenoxyl-4-nitrophenyl)-1-ethyl-N,N'-bis (ethylene)phosphoramidate, compositions and methods for their use and preparationOBI PHARMA INC·Filed 2016·Granted Sep 10, 2019·1 cites·20 claims
- 0564US10668047B2Aziridine containing DNA alkylating agentsMOLECULAR TEMPLATES INC·Filed 2019·Granted Jun 2, 2020·0 cites·11 claims
- 0661US11535585B2Nitrobenzyl derivatives of anti-cancer agentsOBI PHARMA INC·Filed 2020·Granted Dec 27, 2022·0 cites·19 claims
- 0753US2025099779A1Device and method for regulating release of adenosine in organism, and useWENZHOU VENTURA TECH CO LTD·Filed 2023·Application pending·0 cites
- 0852US2018169064A1Aziridine containing dna alkylating agentsTHRESHOLD PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 0950US10829437B2Nitrobenzyl derivatives of anti-cancer agentsOBI PHARMA INC·Filed 2016·Granted Nov 10, 2020·0 cites·16 claims
- 1049US2023339991A1Hypoxia-activated dna alkylating agent and medical use thereofASCENTAWITS PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 1149US2025011348A1Synthesis Process of X-IPM, Stable Crystal Form and Application ThereofASCENTAWITS PHARMACEUTICALS LTD·Filed 2023·Application pending·0 cites
- 1246US2024366640A1Lyophilized formulation solution and lyophilized formulation, and method and use thereofASCENTAWITS PHARMACEUTICALS LTD·Filed 2022·Application pending·0 cites
- 1346US2023026163A1Anticancer compound and medical use thereofASCENTAWITS PHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 1445US2009042820A1Tubulin Binding Anti Cancer Agents And Prodrugs ThereofTHRESHOLD PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 1545US2007060534A1Anthracycline analogsTHRESHOLD PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1640US2025304606A2A deuterated compound, and preparation method and use thereofASCENTAWITS PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 1736US2022251021A1Akr1c3 inhibitor and medical useASCENTAWITS PHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 1834US2022387345A1Anti-cancer compounds acting as non-pgp substrateASCENTAWITS PHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 1932US8486657B2Anti-preproprotein and anti-preprotein antibodies as immunohistochemical markersCAI XIAOHONG·Filed 2010·Granted Jul 16, 2013·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Xiaohong Cai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →